Viewing nowDonepezil 5 mg Tablet (Donepezil Hydrochloride Monohydrate)
Donepezil Hydrochloride Hydrate 5.215mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

MFDS item code 201004729 · Approved 2010.07.28 · Insurance code 645403430
Treatment of symptoms of Alzheimer's disease
This medication is used to slow the progression of symptoms associated with Alzheimer's type dementia and to improve cognitive functions.
Adults: Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, morning administration of this medicine may be considered. Since donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After assessing the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. If administration of this medicine is discontinued, its effects gradually diminish; no rebound effect occurs following abrupt discontinuation. Female patients aged 85 years or older with low body weight: Adverse reactions occur more frequently, so careful monitoring is required. Elderly women with low body weight should not receive more than 5 mg daily.
Pediatrics: There is no experience with use in children.
This medication should not be used by individuals who are allergic to specific drugs or substances. Women who are pregnant or may become pregnant and those who are breastfeeding should not take this medication. This medication is also unsuitable for patients who are genetically unable to digest certain sugars. Patients with heart conditions should be cautious as this medication can cause slow or irregular heartbeats. Patients with a history of peptic ulcers or those taking non-steroidal anti-inflammatory drugs should use this medication carefully, as gastrointestinal symptoms may worsen. Patients with asthma or obstructive pulmonary disease should be careful as bronchoconstriction or increased mucus secretion may worsen symptoms. Patients with extrapyramidal disorders such as Parkinson's disease should consult a physician before taking this medication, as symptoms may worsen. During the use of this medication, side effects such as dizziness, nausea, vomiting, diarrhea, and insomnia may occur, and any abnormal symptoms should be reported to medical personnel immediately. In serious cases, cardiac issues, liver dysfunction, neurological abnormal symptoms, and muscular abnormal symptoms may occur, necessitating regular monitoring. This medication is approved for the treatment of dementia and should not be used for other types of memory disorders, and treatment should be conducted under the supervision of a specialist. Caution is required when driving or operating machinery, as fatigue or dizziness may occur at the beginning of treatment or during dose adjustments. This medication is metabolized by specific enzymes, so drug interactions may alter efficacy; thus, informing medical personnel about ongoing medications is essential. Pregnant or breastfeeding women are advised not to use this medication; if it is necessary to take it, breastfeeding should be suspended. Safety in children has not been established; therefore, it should not be used in pediatric patients. In cases of overdose, there is a risk of severe nausea, vomiting, bradycardia, hypotension, and respiratory depression, so immediate medical attention is required; atropine may be used as an antidote. Store this medication out of reach of children and do not transfer it to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is recommended to maintain a storage temperature between 1°C and 30°C at room temperature to preserve the drug's efficacy for a long time.
This medication is a white, round film-coated tablet.
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 5.215mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.